| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85936e66bc92fdff464ddec40227e8b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_416a4608d5021143d5887482eb7c41f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0683 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 |
| filingDate |
2005-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3353e5e0b6be5c990fdc3a123719fa7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0995f9ead15b6001c0a4eaa6556bb5 |
| publicationDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005113753-A2 |
| titleOfInvention |
Prostatic stem cells, isolation and uses |
| abstract |
Prostatic stem cells have been isolated. Benign prostatic hyperplasia and other proliferative diseases of the prostate may arise in prostatic stem cells. The prostatic stem cells are used as a research tool for studying cancer and other proliferative diseases of the prostate, and for developing diagnostics and therapeutics for proliferative diseases of the prostate. Antibodies to the antigens expressed by prostatic stem cells can be used as therapeutics or diagnostics or can be used to deliver therapeutic or diagnostic agents directly to the prostatic stem cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2272948-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2272948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8747838-B2 |
| priorityDate |
2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |